The electrocardiographic QRS interval reflects ventricular depolarization, and its duration is a function of electrophysiological properties within the His-Purkinje system and the ventricular myocardium. A diseased ventricular conduction system can lead to life-threatening bradyarrhythmias, such as heart block, and tachyarrhythmias, such as ventricular fibrillation. Longer QRS duration is a predictor of mortality and sudden death in the general population and in cohorts with hypertension and coronary artery disease 1-3 . In a population-based study, prolonged baseline QRS was associated with incident heart failure 4 .
genes encoding transcription factors, including locus 5 (HAND1), locus 6 (TBX20), locus 8 (TBX5), locus 9 (TBX3) and locus 19 (KLF12) . Common variation in TBX5 was recently associated with QRS duration 9 . The index signal in the prior report, rs3825214, was in moderate LD with our top signal, rs883079 (r 2 = 0.67).
Additional regions identified include locus 7 (SIPA1L1), locus 10 (VTI1A), locus 11 (SETBP1), locus 13 (TKT-CACNA1D-PRKCD), locus 14 (CRIM1), locus 17 (the nearest gene, IGFBP3, is 660 kb away) and locus 20 (LRIG1).
Collectively, the identified index SNPs across these 20 loci explained approximately 5.7% (± 2.3% (s.d.)) of the observed variance in QRS duration, consistent with a polygenic model in which each of the discovered variants exerts only a modest effect on QRS interval. None of these index SNPs showed a significant interaction with sex or age after Bonferroni correction (Supplementary Table 2 ). We observed moderate levels of heterogeneity of the effect (25 < I 2 < 75) for several index SNPs (Table 1) . However, only HAND1-SAP30L showed significant evidence of heterogeneity using Cochran's Q test corrected for 23 independent genome-wide variants (Cochran's P = 0.005).
Extension of findings in an additional 7,170 individuals
Based on the discovery meta-analysis, we selected the index SNPs at four loci (loci 15, 17, 19 and 20) with P values ranging between P = 5 × 10 −8 and P = 5 × 10 −9 and from all five loci with P values ranging from P = 1 × 10 −6 to P = 5 × 10 −8 (Online Methods) for genotyping in an additional 7,170 European individuals in order to boost the study's power. In a joint analysis combining all 47,577 individuals, the significance for the four loci with P values between P = 5 × 10 −8 and P = 5 × 10 −9 increased, indicating these represent true positive associations ( Table 1) . The joint analysis also provided further evidence for two other loci (locus 21 near DKK1 and locus 22 tagged by an intronic SNP in GOSR2) that reached genome-wide significance, bringing the total number of significant loci to 22, with 25 independently associated index SNPs ( Table 1) . The index SNP (rs1733724) in DKK1 was previously associated with QRS duration in an Icelandic population 9 .
Association with conduction defect
Based on this series of QRS associations, we sought to test the hypothesis that QRS-prolonging alleles, on average, increase risk of ventricular conduction defects. To address this question, we calculated a risk score in each individual by adding up the number of QRS-prolonging alleles identified in this study weighted by the observed effect sizes (β estimates) from the final meta-analysis. In an independent set of 519 individuals from the Atherosclerosis Risk in Communities (ARIC) and Rotterdam (RS) studies with bundle branch block or nonspecific prolongation of QRS interval (QRS > 120 milliseconds (ms)) compared with those individuals with normal conduction (N = 12,804), we found evidence that the cumulative burden of QRS-prolonging alleles is associated with risk of ventricular conduction defect (P = 0.004). This result was largely driven by those individuals with nonspecific 1  2  3  4  5  6  7  8 9 10 11 12 13 14 15 1617 18 20 22  Chromosome   NFIA   RNF11-CDKN2C   CASQ2   CRIM1-STRN   TKT-CACNA1D   LRIG1-SLC25A26   HAND1-SAP30L   SCN5A-SCN10A   PLN   TBX20   CDKN1A   IGFBP3  DKK1   VTI1A TBX5-TBX3  KLF12   SIPA1L1 PRKCA GOSR2 SETBP1 Figure 1 Manhattan plot. A r t i c l e s intraventricular conduction defects, as opposed to those with left or right bundle branch block ( Supplementary Table 3a ,b). Similar results were observed using an unweighted genotype risk score.
Putative functional variants
Of the 612 genome-wide significant SNPs, one in SCN5A (rs1805124, His558Arg, P = 2.4 × 10 −18 ), two in SCN10A (rs12632942, Leu1092Pro, P = 5.1 × 10 −11 , and rs6795970, Ala1073Val, P = 5 × 10 −27 ), one in C6orf204 near PLN (rs3734381, Ser137Gly, P = 1.1 × 10 −10 ) and one in CASQ2 (index SNP rs4074536, Thr66Ala, P = 2.4 × 10 −8 ) were non-synonymous ( Fig. 2 and Supplementary Fig. 2) . The PolyPhen-2 program predicts all five of these variants to be benign, which is consistent with small-effect associations: each copy of the minor allele was associated with cross-sectional differences in QRS duration of less than 1 ms. The 25 index SNPs ( Table 1) were subsequently tested for association with gene cis expression levels in 1,240 PAXgene whole blood samples 10 . Four cis expression QTLs (eQTLs) were detected after stringent Bonferroni correction (Supplementary Fig. 3) . The most notable eQTLs were observed for probes in exonic regions of TKT (rs4687718, P = 5.87 × 10 −70 ) and CDKN1A (rs9470361, P = 1.41 × 10 −10 ) and in an intronic probe for C6orf204 near PLN (rs11153730, P = 1.54 × 10 −10 ). We additionally assessed cis regulation for all HapMap SNPs for these three loci (± 250 kb around the SNPs). The top eSNPs for TKT (rs9821134) and C6orf204 (rs11970286) were in moderate to high LD (r 2 = 0.47 and r 2 = 0.91, respectively) with the top QRS signals at these loci. However, the top eSNP for CDKN1A, rs735013, was only weakly correlated with the QRS index SNP rs9470361 (r 2 = 0.089). In a conditional analysis that included both CDKN1A locus SNPs in the regression model, both rs735013 and rs9470361 remained independently associated with expression levels (P = 1.7 × 10 −9 and P = 2.3 × 10 −5 , respectively). Additionally, rs735013 itself was marginally associated with QRS duration (coded allele frequency = 0.39, β = 0.33 ms (s.e. = 0.07 ms), P = 2.4 × 10 −6 ). Whether these associations in whole blood samples will be similar to associations in cardiac myocytes and conduction tissue deserves further investigation.
Pleiotropic effects of ECG-associated variants
To explore the shared genetic underpinnings between atrial and ventricular depolarization and conduction (as measured by PR and QRS intervals) as well as ventricular depolarization and repolarization (QRS and QT intervals), we examined the effects of previously published PR and QT SNPs with respect to QRS interval. Several QRS loci were In each locus, at least one marker exceeded the genome-wide significance threshold of P < 5 × 10 −8 . At locus 1, six signals were identified (r 2 < 0.05) that exceeded this genomewide threshold. In a multi-SNP model that included all six SNPs, there was evidence that at least four of these SNPs were independently associated with QRS duration. The bolded allele is the coded allele. β values estimate the difference in QRS interval in milliseconds per copy of the coded allele, adjusted for the covariates in the model. Chr., chromosome; AF, coded allele frequency; s.e., standard error; GC, genomic-control adjusted; UTR, untranslated region. AF is an average weighted by study size.
previously associated with PR or QT intervals, including PLN, TBX5-TBX3 and SCN5A-SCN10A, the last of which is associated with all three traits ( Supplementary Table 4a ). We also tested 9 PR SNPs and 16 QT SNPs for their effect on QRS duration ( Supplementary Table 4b ) [11] [12] [13] . Our results suggest roles for CAV1-CAV2 (rs3807989, P = 5.8 × 10 −6 ) and NOS1AP (rs12143842, P = 1.3 × 10 −4 ) in QRS duration. Indeed CAV1-CAV2 was recently associated with QRS interval 9 . QRS duration is positively correlated with both PR interval (r = 0.09) and QT interval (r = 0.44) 9 . To test if these relationships are also observed genetically, we compared the directionality of the association of SNPs at the published PR and QT loci with those for QRS duration. Generally, the effects of SNPs on PR interval were positively correlated with their effects on QRS duration (r = 0.53). With the exception of TBX3, the loci influencing both PR and QRS intervals (SCN5A, SCN10A, TBX5 and CAV1-CAV2) do so in a concordant fashion (that is, variants that prolong PR also prolong QRS duration) ( Fig. 3 and Supplementary Table 4a ,b). By contrast, although QT and QRS are positively correlated at the population level, the effects of SNPs on QT interval were marginally negatively correlated with their effects on QRS interval (r = −0.08). Of the index SNPs at the four loci significantly associated with both QT and QRS interval (SCN5A-SCN10A, PRKCA, NOS1AP and PLN), only the PLN locus SNPs showed effects in the same direction ( Fig. 3 and Supplementary Table 4a ,b).
Bioinformatic network analysis of QRS-associated loci
To examine the relationships between genetic loci associated with QRS duration, we developed an in silico relational network linking the loci based on published direct gene product interactions obtained from curated databases ( Supplementary Fig. 4 ) 14 . Most loci meeting genome-wide significance mapped to this network after a minimum number of 'linker' nodes were incorporated to create a spanning network. This analysis provides a graphical overview of the interconnections among QRS-associated genetic loci and highlights both known and putative molecular mechanisms regulating ventricular conduction (see below for further discussion). Several of the 'linker' nodes incorporated in the network, such as GJA1 (encoding connexin 43), NEDD4, KCNMA1 and RYR2, are known modulators of cardiac electrical activity. Functional enrichment analysis of the QRS-associated network nodes (that is, loci with P < 5 × 10 −8 ) using two independent software tools revealed that programs involved in heart development were highly overrepresented (P value range: P = 5.8 × 10 −6 to P = 9.6 × 10 −5 ) 15, 16 .
SCN10A function in a mouse model
We undertook functional studies to determine whether our most significant locus was associated with ventricular conduction in mice. Transcriptional profiling suggests that Scn10a mRNA, which encodes the Na v 1.8 sodium channel, is expressed in the ventricular myocardium and at higher levels in the specialized conduction system 17 . These data were confirmed and extended by quantitative Figure 3 Pleiotropic associations of PR, QRS and QT loci. Electrocardiographic tracing delineating the PR, QRS and QT intervals. PR and QRS intervals reflect myocardial depolarization and conduction time through the atria and down the atrioventricular node (PR) and throughout the ventricle (QRS) and are weakly positively correlated (r = 0.09). The majority of loci that influence both PR and QRS (SCN5A, SCN10A, TBX5 and CAV1-2) do so in a concordant fashion (meaning variants that prolong PR duration also prolong QRS duration). The notable exception is a region on chromosome 12, where variants in the TBX5 locus have a concordant effect, whereas those in nearby TBX3 have a discordant effect. By contrast, although QRS (ventricular depolarization) and QT (ventricular repolarization) are moderately positively correlated, the majority of loci (SCN5A, SCN10A, PRKCA and NOS1AP) that influence both phenotypes do so in a discordant fashion (meaning variants that prolong the QRS interval shorten the QT interval). The exception is the locus at PLN, where the variants have a concordant effect. 1 0 7 2 VOLUME 42 | NUMBER 12 | DECEMBER 2010 Nature GeNetics A r t i c l e s PCR (Fig. 4a) , demonstrating a 25.7-fold ± 1.1-fold (s.e.) enrichment of Scn10a Na v 1.8 in Purkinje cells compared to working ventricular myocytes (n = 3 for each cell type; P = 0.002). Telemetric electrocardiographic recordings (lead II position) were obtained in conscious mice treated with A-803467, a potent Scn10a Na v 1.8 antagonist, which blocks Na v 1.8 100 times more potently than Na v 1.5 with the doses used 18 . These studies showed a significant increase in QRS duration (11.6 ms (± 2.6 ms (s.e.)) to 14.5 ms (± 0.54 ms), n = 7, P < 0.001), whereas treatment with vehicle alone was without effect (11.4 ms (± 0.29 ms) to 11.9 ms (± 0.42 ms), n = 7, P value was not significant). The PR interval was also increased in drugtreated mice, from 31.4 ms (± 0.98 ms) to 42.5 ms (± 3.3 ms), n = 7, P < 0.01), whereas treatment with vehicle alone resulted in no significant change (32.6 ms (± 1.0 ms) to 33.4 ms (± 0.69 ms), n = 7, P value was not significant) ( Fig. 4b) . To further delineate the site of ventricular conduction slowing, we performed intra-cardiac recordings from mice treated with A-803467. These studies confirmed the significant increase in QRS duration (from 12.26 ms (± 0.62 ms) to 14.56 ms (± 0.58 ms), n = 7, P = 0.015), whereas treatment with vehicle alone was without significant effect (12.39 ms (± 0.52 ms) to 13.65 ms (± 0.97 ms), n = 5, P value was not significant). A-803467 treatment resulted in a 35.7% ± 1.2% increase in HV interval (from 9.33 ms (± 0.74 ms) to 12.67 ms (± 1.06 ms), P = 0.009), whereas treatment with vehicle alone was without significant effect (10.67 ms (± 0.83 ms) to 11.17 ms (± 1.10 ms, P value was not significant) ( Fig. 4c) . Taken together, these data indicate that the QRS prolongation may primarily reflect conduction slowing in the specialized ventricular conduction system.
DISCUSSION
Our meta-analysis of 14 GWAS consisting of 40,407 individuals of European descent with additional genotyping in 7,170 Europeans yielded genome-wide significant associations of QRS duration with common variants in 22 loci. Variations in four of these loci (locus 1, SCN5A-SCN10A; locus 2, CDKN1A; locus 8, TBX5; and locus 21, DKK1) were previously associated with QRS duration in smaller independent studies using both candidate gene and genome-wide approaches 7-9 . The 22 loci include genes in a number of interconnected pathways, including some previously known to be involved in cardiac conduction, such as sodium channels, calcium-handling proteins and transcription factors, as well as previously unidentified processes not known to be involved in cardiac electrophysiology, such as kinase inhibitors, growth factor-related genes and others.
The electrocardiographic QRS interval reflects ventricular depolarization and conduction time. Ventricular myocyte depolarization occurs through cardiac membrane excitatory inward currents mediated by voltage-gated sodium channels 19 . The primary determinants of conduction velocity are the magnitude of excitatory inward currents flowing through these sodium channels, the extent of cellto-cell communication through gap junction-connexin coupling, and cell and tissue architecture and morphology 19 . Multiple pathways suggested in this study determine or modulate these key components of ventricular depolarization and conduction. Candidate genes in these pathways are briefly discussed in Box 1.
Our strongest association signal (locus 1) mapped in or near two voltage-gated sodium channel genes: SCN5A and SCN10A. SCN5A encodes the cardiac Na v 1.5 sodium channel and is well known for its role in cardiac conduction and other cardiovascular and electrophysiologic phenotypes 20, 21 . SCN10A encodes the Na v 1.8 sodium channel. We provide new data demonstrating that the SCN10A transcript and product is preferentially expressed in the mouse His-Purkinje system compared with the ventricular myocardium, and that Na v 1.8 channel blockers result in QRS and HV interval prolongation, indicative of a slowing of impulse propagation in the specialized ventricular conduction system and a delayed activation of the ventricular myocardium. Notably, a recent study reported shortening of the PR interval in Scn10a knockdown mice and concluded that Na v 1.8 prolongs cardiac conduction and that rs6795970, encoding the A1073V variant, is a gain-of-function allele 8 . Alternatively, the more rapid conduction they observed in the knockdown mice could reflect compensatory upregulation of TTX-sensitive currents, a phenomenon previously observed in Na v 1.8-deficient DRG neurons 22 .
We and others demonstrated previously that, in addition to their association with QRS duration, variants in SCN5A and SCN10A are associated with atrial conduction (PR interval) and myocardial repolarization (QT interval), as well as atrial and ventricular fibrillation 8, 9, 13 . These results emphasize the crucial role played by these genes in cardiac conduction and the generation of arrhythmias.
Calcium regulation is integral to impulse propagation, modulating cellular electrophysiology, including sodium channel and gap-junction function, as well as tissue architecture 20, 23, 24 . Several of the loci associated with QRS duration contain genes directly related to calcium processes. As depicted in Supplementary Figure 4 and detailed in Box 1, these genes encode interrelated proteins that influence Ca 2+ signaling (PLN in locus 3; PRKCA in locus 16; and CASQ2 in locus 18) and downstream effects (STRN in locus 12).
Transcription factors regulating embryonic electrophysiologic development are critical for the integrity of impulse conduction 25 . We identified six transcription factors (TBX3 in locus 9; TBX5 in locus 8; TBX20 in locus 6; HAND1 in locus 5; NFIA in locus 4; and KLF12 in locus 19) in loci associated with QRS duration. Several of these transcription factors affect cardiac morphogenesis and may influence conduction by altering cellular and tissue architecture. Notably, they may also have direct electrophysiologic consequences by modifying factors involved in impulse conduction. For example, HAND1 and T-box factors regulate GJA5 (encoding connexin 40) and/or GJA1 (encoding connexin 43), and TBX5 binds to the ATP2A2 (also known as SERCA2A) promoter 26 .
Our study suggests a number of processes and pathways not previously known to be involved in cardiac electrophysiology, including cyclin-dependent kinase inhibitors and genes related to tumorigenesis and cellular transformation. How these previously unidentified processes influence QRS duration remains to be defined.
In pleiotropic analyses, most variants influencing both PR and QRS interval, with the exception of TBX3, were concordant in effect direction, consistent with the known shared physiologic processes underlying the two traits: depolarization and conduction time in the sino-atrial node,
Box 1 Noteworthy genes within loci associated with Qrs duration
Of the 22 loci identified, common variants in four loci (SCN5A-SCN10A, CDKN1A, TBX5 and DKK1) were previously associated with QRS duration in genetic association studies. Mutations in two loci (SCN5A and TBX5) lead to inherited syndromes associated with conduction disease. Animal experiments show a role for several additional loci (HAND1, TBX3 and TBX5) in cardiac ventricular conduction, as detailed below. The remainder are new QRS loci, and their role in cardiac conduction remains to be elucidated.
(1) cardiac sodium channel genes:
• SCN5A (locus 1): SCN5A encodes the cardiac Na v 1.5 sodium channel and is well known to influence cardiac conduction, as well as other cardiovascular and electrophysiologic phenotypes 20,21 .
• SCN10A (locus 1): SCN10A encodes the Na v 1.8 sodium channel, present in both ventricular myocardium and conduction fibers. Selective SCN10A blocker prolongs QRS interval.
(2) calcium-handling proteins:
• CASQ2 (locus 18): CASQ2 regulates opening of the ryanodine receptor (encoded by RYR2) 28, 29 . Cellular depolarization through sodium channels triggers calcium influx through L-type calcium channels, which in turn provokes RYR2-mediated calcium release from the sarcoplasmic reticulum. CASQ2 mutations have been associated with catecholaminergic polymorphic ventricular tachycardia 30, 31 .
• PLN (locus 3): Calcium uptake into the sarcoplasmic reticulum by SERCA2a is regulated by PLN (encoding cardiac phospholamban) 32 . The phosphorylation state of PLN is dependent on signaling pathways involving phosphatases and kinases, including that encoded by PRKCA 41 . We previously demonstrated that this locus is associated with both cardiac electrical properties (QT interval duration and heart rate) and size (left ventricular end diastolic dimension) in genome-wide association analyses 11, 12, 33, 34 .
• PRKCA (locus 16): Protein kinase C alpha activity affects dephosphorylation of the sarcoplasmic reticulum Ca 2+ ATPase-2 (SERCA-2) pump inhibitory protein phospholamban (PLN) and alters sarcoplasmic reticulum Ca 2+ loading and the Ca 2+ transient 35 .
• STRN (locus 12): Striatin is a Ca 2+ -calmodulin binding protein that directly binds to caveolin scaffolding protein. Striatin has recently been implicated in a canine model of arrhythmogenic right ventricular cardiomyopathy 36, 37 .
(3) transcription factors:
• TBX3 (locus 9) and TBX5 (locus 8): TBX3 and TBX5 encode transcription factors found in the cardiac conduction system. TBX5 (activator) competes with TBX3 (repressor) for the regulation of working myocardial genes such as GJA1 38, 39 . Common variations near TBX3 and TBX5 were associated with PR and QRS durations 9, 13 . Mutations in TBX3 and TBX5 have been associated with rare inherited syndromes manifested by an array of defects including ventricular structural and/or conduction defects.
• TBX20 (locus 6): TBX20 demarcates the left and right ventricles 40 and mutations in TBX20 have been implicated in multiple structural defects in mouse and human models 41, 42 .
• HAND1 (locus 5): HAND1 encodes a transcription factor essential to cardiac morphogenesis 43 , with a mutation in this gene having been identified in human hearts with septal defects 44 . Overexpression of Hand1 in the adult mouse heart leads to loss of connexin 43 (encoded by GJA1) expression, QRS prolongation and predisposition to ventricular arrhythmia 45 (4) cyclin dependent kinase inhibitors:
• CDKN1A (locus 2): CDKN1A is a negative regulator of cell cycle entry into G2/M phase and is upregulated by ERBB2 activation. ERBB2, encoding a member of the EGF-receptor family of tyrosine kinases, is essential for proper heart development, and its ligand neuregulin-1 promotes formation of the murine cardiac conduction system 46 . Furthermore, ERBB2 can modulate gap junction assembly and alter appropriate phosphorylation of connexin 43 in glial cells 47 . In addition, CDKN1A is upregulated by PRKCA (locus 16) 48 .
• CDKN2C (locus 15): A member of the family of cyclin-dependent kinase inhibitors that prevent the activation of the CDK kinases, thus functioning as a cell-growth regulator that controls cell cycle G1 progression.
(5) Other pathways:
• CRIM1 (locus 14): CRIM1, encoding a cell-surface transmembrane protein that may bind to various members of the TGF-beta superfamily of ligands, is expressed in mouse and human cardiac tissues 49, 50 . CRIM1 interacts with bone morphogenetic proteins, which induce the expression of CDKN1A (p21) 49, 51 .
• LRIG1 (locus 20): LRIG1 is upregulated in malignancies. It negatively regulates the proto-oncogenic, tyrosine kinase receptor family ERBB2 (ref. 52 ).
• SETBP1 (locus 11): SETBP1 encodes a ubiquitously expressed protein that binds to SET (ref. 53) . The SETBP1-SET interaction has been hypothesized to be a component in tumor development.
• TKT (locus 13): Transketolase (TKT) is a ubiquitous enzyme used in multiple metabolic pathways, including the pentose phosphate pathway 54 .
• DKK1 (locus 21): DKK1, implicated in several tumors, inhibits the Wnt signaling pathway 55 . Wnt signaling is an important modulator of connexin43dependent intercellular coupling in the heart 56 . In cardiac tissue, it has an embryologic role with regard to axial development 57 .
• SIPA1L1 (locus 7): SIPA1L1 appears to play a role in non-canonical Wnt signaling and contributes to development 58 . 1 0 7 4 VOLUME 42 | NUMBER 12 | DECEMBER 2010 Nature GeNetics A r t i c l e s atria and atrioventricular node (PR interval) and depolarization and conduction time in the ventricles (QRS interval). By contrast, although QRS (ventricular depolarization) and QT (ventricular repolarization) are moderately positively correlated, most loci influencing both traits showed discordant effect directions (with the exception of the PLN locus). Investigating the physiologic foundations for these concordant and discordant PR-QRS and QT-QRS relationships could be particularly informative for elucidating the mechanisms by which these loci influence cardiac depolarization, conduction and repolarization.
Several limitations of our study should be considered. First, although we have identified 22 loci significantly associated with QRS duration, the broad nature of LD among common variants generally precludes an unambiguous identification of the culprit variant or of the functional gene. For several genes (SCN5A, SCN10A, C6orf204 and CASQ2), there are common coding SNPs in high LD with the index SNP, which may lend some support for a functional role for these genes. Furthermore, our expression analysis in blood revealed very strong cis-eQTL associations for TKT and CDKN1A, lending additional support to these genes as functional candidates. It would be desirable to perform similar eQTL analyses based on expression data in myocardial cells or in conduction tissue. For our top signal in SCN10A, a gene which until recently was not known to be expressed in the heart, our functional work in mice confirms that SCN10A is involved in ventricular depolarization and conduction. Further fine mapping is needed at all 22 loci to conclusively test all genetic variation (rare and common) for a role in QRS modulation.
To minimize the potential for confounding due to population substructure, we limited our analyses to individuals of European descent, a population for which we could assemble the largest number of samples. At the individual study level, the GWAS showed very little evidence for gross stratification (genomic inflation factor, λ GC , values ranged from 1.00 to 1.05). However, one of our QRS loci, mapping to HAND1-SAP30L, showed evidence of heterogeneity. In genetic association studies, heterogeneity can be due to sampling error, differences in phenotypic measurement, differences in LD structure between populations, technical artifacts, or genuine biological heterogeneity, but it would be difficult to conclude on the basis of our data here which of these is the most likely explanation 27 .
Our study underscores the power of a large genome-wide association study to extend prior biological understanding of cardiac ventricular conduction. Better understanding of the complex biologic pathways and molecular genetics associated with cardiac conduction and QRS duration may offer insight into the molecular basis underlying the pathogenesis of conduction abnormalities that can result in increased risk of sudden death, heart failure and cardiac mortality. 
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identify Gene Ontology categories overrepresented among the QRS-associated loci relative to the entire human genome background 15, 16 . A modified version of Fisher's Exact test (DAVID) and the hypergeometric test (GOTM) were used to determine the probability that a functional category is enriched compared to that expected from random chance.
Mouse model. Quantitative real-time PCR. Enhanced green fluorescent protein (EGFP) + Purkinje cells and EGFP − ventricular myocytes were isolated from neonatal Cntn2-EGFP transgenic mice by fluorescence-activated cell sorting 17, 64 . Quantitative PCR was performed user primers ( Supplementary  Table 5 ) for SCN10A and ribosomal S26 as an internal reference using the 2-ΔΔCT method 65 .
Electrophysiologic testing. Telemetric devices (DSI) were implanted into adult CD1/129SI/SV1MJ mice and recordings were obtained before and 30 min after intraperitoneal injection of the Na v 1.8 antagonist A-803467 (100 mg/kg) 66 . Intracardiac recordings were obtained using an open-chest model under isoflurane anesthesia (1.5% v/v) using an octapolar catheter (EPR-800, Millar Instruments) placed in the right jugular vein.
